Showing results (51-60 of 1,273) with videos related to

Sort By:
Pageof 128
Veterinary and Comparative Oncology|November 21, 2017
Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancersJ-H Kim, A M Frantz, A L Sarver, et al.
Veterinary and Comparative Oncology|November 21, 2017
Faecal microbiota in dogs with multicentric lymphomaA Gavazza, G Rossi, G Lubas, et al.
Veterinary and Comparative Oncology|December 28, 2018
Evaluation of urinary and serum level of chemokine (C-C motif) ligand 2 as a potential biomarker in canine urothelial tumoursN Shimizu, A Hamaide, M Dourcy, et al.
Veterinary and Comparative Oncology|November 29, 2019
The controversial histologic classification of canine subcutaneous whorling tumours: The path to perivascular wall tumoursGiancarlo Avallone, Damiano Stefanello, Roberta Ferrari, et al.
Veterinary and Comparative Oncology|October 31, 2019
Clinical value of carcinoembryonic antigen in mammary neoplasms of bitchesIgor L S Senhorello, Erika M Terra, Felipe A R Sueiro, et al.
Veterinary and Comparative Oncology|December 14, 2017
Anticancer effects of resveratrol in canine hemangiosarcoma cell linesA Carlson, K S Alderete, M K O Grant, et al.
Veterinary and Comparative Oncology|December 22, 2017
Expression of the glutamine metabolism-related proteins glutaminase 1 and glutamate dehydrogenase in canine mammary tumoursJ-E Ryu, H-K Park, H-J Choi, et al.
Veterinary and Comparative Oncology|January 27, 2019
Differentially expressed microRNAs, including a large microRNA cluster on chromosome 24, are associated with equine sarcoid and squamous cell carcinomaKirsten Bogedale, Vidhya Jagannathan, Vinzenz Gerber, et al.
Veterinary and Comparative Oncology|March 7, 2018
Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomideG Polton, R Finotello, S Sabattini, et al.
Veterinary and Comparative Oncology|June 24, 2016
Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53D York, S S Withers, K D Watson, et al.
Pageof 128